Probiotics and Herbals as a Boom in Treatment of Ulcerative Colitis

IF 0.4 Q4 PHARMACOLOGY & PHARMACY
Sankha Bhattacharya
{"title":"Probiotics and Herbals as a Boom in Treatment of Ulcerative Colitis","authors":"Sankha Bhattacharya","doi":"10.22377/ajp.v14i2.3627","DOIUrl":null,"url":null,"abstract":"Ulcerative colitis (UC) is an inflammatory chronic disease primarily affecting the colonic mucosa; the extent and severity of colon involvement are variable. In its most limited form, it may be restricted to the distal rectum, while in its most extended form, the entire colon is involved. UC is identified by mucus diarrhea, tenesmus, bowel distension, and anemia. 5-aminosalicylic acid drugs, steroids, and immunosuppressant are used for therapy of UC. The annual occurrence of disease in Asia, America, and Europe was estimated to be 6.3, 19.2, and 24.3/100,000 people years. The main challenges in the management of the disease are drug-related side effects and local targeting. To overcome these challenges, probiotics overcome drug-related adverse side effects and local targeting. On ingestion, the probiotics can result in health beneficial effects. Probiotics are mainly used as gut modulators but are also nowadays explored for their use in UC.","PeriodicalId":8489,"journal":{"name":"Asian Journal of Pharmaceutics","volume":null,"pages":null},"PeriodicalIF":0.4000,"publicationDate":"2020-06-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"4","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Asian Journal of Pharmaceutics","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.22377/ajp.v14i2.3627","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 4

Abstract

Ulcerative colitis (UC) is an inflammatory chronic disease primarily affecting the colonic mucosa; the extent and severity of colon involvement are variable. In its most limited form, it may be restricted to the distal rectum, while in its most extended form, the entire colon is involved. UC is identified by mucus diarrhea, tenesmus, bowel distension, and anemia. 5-aminosalicylic acid drugs, steroids, and immunosuppressant are used for therapy of UC. The annual occurrence of disease in Asia, America, and Europe was estimated to be 6.3, 19.2, and 24.3/100,000 people years. The main challenges in the management of the disease are drug-related side effects and local targeting. To overcome these challenges, probiotics overcome drug-related adverse side effects and local targeting. On ingestion, the probiotics can result in health beneficial effects. Probiotics are mainly used as gut modulators but are also nowadays explored for their use in UC.
益生菌和草药治疗溃疡性结肠炎的热潮
溃疡性结肠炎(UC)是一种主要影响结肠粘膜的炎症性慢性疾病;结肠受累的程度和严重程度各不相同。在其最有限的形式中,它可能局限于直肠远端,而在其最延伸的形式中则涉及整个结肠。UC可通过粘液性腹泻、里急后重、肠胀和贫血来确定。5-氨基水杨酸药物、类固醇和免疫抑制剂用于UC的治疗。据估计,亚洲、美洲和欧洲的年发病率分别为6.3、19.2和24.3/10万人年。该疾病管理的主要挑战是与药物相关的副作用和局部靶向。为了克服这些挑战,益生菌克服了与药物相关的不良副作用和局部靶向。摄入益生菌后,可产生有益健康的效果。益生菌主要用作肠道调节剂,但目前也在探索其在UC中的应用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Asian Journal of  Pharmaceutics
Asian Journal of Pharmaceutics PHARMACOLOGY & PHARMACY-
自引率
0.00%
发文量
47
期刊介绍: Character of the publications: -Pharmaceutics and Pharmaceutical Technology -Formulation Design and Development -Drug Discovery and Development Interface -Manufacturing Science and Engineering -Pharmacokinetics, Pharmacodynamics, and Drug Metabolism -Clinical Pharmacology, General Medicine and Translational Research -Physical Pharmacy and Biopharmaceutics -Novel Drug delivery system -Biotechnology & Microbiological evaluations -Regulatory Sciences
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信